Keratinocyte

"Skin keratinocyte proliferation" refers to the process by which **keratinocytes**, the predominant cell type in the epidermis, multiply and expand their population. This process is essential for maintaining skin homeostasis, enabling wound healing, and responding to injury. Keratinocyte proliferation is regulated by various extracellular cues including growth factors (notably epidermal growth factor [EGF] signaling via the EGF receptor), cytokines, cell-cell adhesion molecules, and interactions with the extracellular matrix. Dysregulation of this process can contribute to pathological conditions such as cancer (including squamous cell carcinoma), chronic inflammation, or abnormal scar formation like keloids[1][3][4]. **Notes on correctness:** "Skin keratinocyte proliferation" describes a biological process rather than a specific molecular target or receptor. The actual therapeutic targets involved in regulating this process include molecules such as the **epidermal growth factor receptor (EGFR)**[1]. Therefore: - The entry is not a canonical molecular target but rather a cellular function. - For structured data purposes, it would be more appropriate to focus on specific regulators of this process (e.g., EGFR) if you are seeking druggable targets or receptors. If you need information about an actual therapeutic target involved in skin keratinocyte proliferation—such as "Epidermal growth factor receptor"—please specify so that detailed structured information can be provided for that molecule.

Other names

Epidermal keratinocyteSkin keratinocyte